Treatment of postmenopausal women with locally advanced or metastatic breast cancer with letrozole alone or in combination with temsirolimus:: a randomized, 3-arm, phase 2 study

被引：0
|
作者：
Baselga, J
Roché, H
Fumoleau, P
Campone, M
Colomer, R
Cortes-Funes, H
Gil, M
Chan, S
Boni, J
Kong, S
Cincotta, M
Moore, L
机构：
[1] Hosp Valle De Hebron, Barcelona, Spain
[2] Inst Claudius Regaud, Toulouse, France
[3] Ctr Rene Gauducheau, St Herblain, France
[4] Inst Catala Oncol, Girona, Spain
[5] Hosp Univ 12 Octubre, Madrid, Spain
[6] Inst Catala Oncol, Barcelona, Spain
[7] City Hosp Nottingham, Nottingham, England
[8] Wyeth Res, Collegeville, PA USA
[9] Wyeth Res, Cambridge, MA USA
来源：
BREAST CANCER RESEARCH AND TREATMENT | 2005年 / 94卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：S62 / S62
页数：1
相关论文
共 50 条
  • [31] A randomized phase 2 study of sapanisertib in combination with paclitaxel versus paclitaxel alone in women with advanced, recurrent, or endometrial cancer
    Han, Sileny N.
    Oza, Amit
    Colombo, Nicoletta
    Oaknin, Ana
    Raspagliesi, Francesco
    Wenham, Robert M.
    Braicu, Elena Ioana
    Jewell, Andrea
    Makker, Vicky
    Krell, Jonathan
    Alia, Eva Maria Guerra
    Baurain, Jean-Francois
    Su, Zhenqiang
    Neuwirth, Rachel
    Vincent, Sylvie
    Sedarati, Farhad
    Faller, Douglas, V
    Scambia, Giovanni
    GYNECOLOGIC ONCOLOGY, 2023, 178 : 110 - 118
  • [32] Phase II study of trastuzumab and pertuzumab alone and in combination with hormonal therapy or chemotherapy with eribulin in women aged ≥60 with HER2/neu overexpressed locally advanced and/or metastatic breast cancer
    Rosenblatt, P. Y.
    Kesmodel, S. D.
    Bellavance, E.
    Nichols, E. M.
    Feigenberg, S. J.
    Tait, N.
    Lewis, J.
    Sivisailam, S. S.
    Couzi, R.
    Goloubeva, O.
    Tkaczuk, K. H. R.
    CANCER RESEARCH, 2016, 76
  • [33] Palbociclib Plus Letrozole as First-Line Therapy in Postmenopausal Asian Women With Metastatic Breast Cancer: Results From the Phase III, Randomized PALOMA-2 Study
    Im, Seock-Ah
    Mukai, Hirofumi
    Park, In Hae
    Masuda, Norikazu
    Shimizu, Chikako
    Kim, Sung-Bae
    Im, Young-Hyuck
    Ohtani, Shoichiro
    Bartlett, Cynthia Huang
    Lu, Dongrui R.
    Iyer, Shrividya
    Mori, Yuko
    Mori, Ave
    Gauthier, Eric
    Finn, Richard S.
    Toi, Masakazu
    JOURNAL OF GLOBAL ONCOLOGY, 2019, 5 : 1 - 19
  • [34] Bosutinib in Combination With the Aromatase Inhibitor Letrozole: A Phase II Trial in Postmenopausal Women Evaluating First-Line Endocrine Therapy in Locally Advanced or Metastatic Hormone Receptor-Positive/HER2-Negative Breast Cancer
    Moy, Beverly
    Neven, Patrick
    Lebrun, Fabienne
    Bellet, Meritxell
    Xu, Binghe
    Sarosiek, Tomasz
    Chow, Louis
    Goss, Paul
    Zacharchuk, Charles
    Leip, Eric
    Turnbull, Kathleen
    Bardy-Bouxin, Nathalie
    Duvillie, Ladan
    Lang, Istvan
    ONCOLOGIST, 2014, 19 (04): : 348 - 349
  • [35] Phase Ib study to assess the safety, tolerability, and clinical activity of gedatolisib in combination with palbociclib and either letrozole or fulvestrant in women with metastatic or locally advanced/recurrent breast cancer (B2151009)
    Forero, Andres
    Han, Hyo Sook
    Dees, Elisabeth C.
    Wesolowski, Robert
    Bardia, Aditya
    Kabos, Peter
    Kern, Kenneth A.
    Perea, Rachelle
    Pierce, Kristen J.
    Houk, Brett
    Rugo, Hope S.
    CANCER RESEARCH, 2018, 78 (04)
  • [36] Cyclophosphamide, doxorubicin, and gemcitabine combination chemotherapy for treatment of metastatic and locally advanced breast cancer
    Levin, M
    Durgam, S
    Novetsky, A
    CANCER INVESTIGATION, 2002, 20 (7-8) : 872 - 875
  • [37] A Phase I/Ib Study of Enzalutamide Alone and in Combination with Endocrine Therapies in Women with Advanced Breast Cancer
    Schwartzberg, Lee S.
    Yardley, Denise A.
    Elias, Anthony D.
    Patel, Manish
    LoRusso, Patricia
    Burris, Howard A.
    Gucalp, Ayca
    Peterson, Amy C.
    Blaney, Martha E.
    Steinberg, Joyce L.
    Gibbons, Jacqueline A.
    Traina, Tiffany A.
    CLINICAL CANCER RESEARCH, 2017, 23 (15) : 4046 - 4054
  • [38] Palbociclib in combination with letrozole as first-line treatment for advanced breast cancer: A Japanese phase II study
    Masuda, Norikazu
    Nishimura, Reiki
    Takahashi, Masato
    Inoue, Kenichi
    Ohno, Shinji
    Iwata, Hiroji
    Mori, Yuko
    Hashigaki, Satoshi
    Muramatsu, Yasuaki
    Nagasawa, Takashi
    Umeyama, Yoshiko
    Toi, Masakazu
    CANCER SCIENCE, 2018, 109 (03): : 803 - 813
  • [39] Phase II trial of goserelin and exemestane combination therapy in premenopausal women with locally advanced or metastatic breast cancer.
    Wang, Jiayu
    Xu, Binghe
    Yuan, Peng
    Ma, Fei
    Li, Qing
    Zhang, Pin
    Luo, Yang
    Cai, Ruigang
    Fan, Ying
    Li, Qiao
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [40] Gemcitabine in combination with cisplatin (GP) versus gemcitabine (G) alone in the treatment of locally advanced or metastatic pancreatic cancer: Final results of a multicenter randomized phase II study.
    Viret, F
    Ychou, M
    Lepille, D
    Mineur, L
    Navarro, F
    Topart, D
    Fonck, M
    Goineau, J
    Madroszyk-Flandin, A
    Chouaki, N
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 342S - 342S
12345